The most recent HF guidelines in the United States and Europe recommend that first-line treatment for patients with HF with reduced ejection fraction (HFrEF) or HF with preserved ejection fraction (HFpEF) should include SGLT2 inhibitors and diuretics (26). Here, SLC5A2 is linked to hydrops fetalis.